Literature DB >> 19655276

Enhancement of human gamma-interferon production in recombinant E. coli using batch cultivation.

Valiollah Babaeipour1, Seyed Abbas Shojaosadati, Rasoul Khalilzadeh, Nader Maghsoudi, Amir Mohammad Farnoud.   

Abstract

Development of inexpensive and simple culture media and appropriate induction conditions are always favorable for industry. In this research, chemical composition and stoichiometric data for gamma-interferon production and recombinant Escherichia coli growth were used in order to achieve a simple medium and favorable induction conditions. To achieve this goal, the effects of medium composition and induction conditions on the production of gamma-interferon were investigated in batch culture of E. coli BL21 (DE3) [pET3a-ifngamma]. These conditions were considered as suitable conditions for the production of gamma-interferon: 2.5x M9 medium, supplemented with a mixture of amino acids (milligram per liter), including glutamic acid 215, aspartic acid 250, lysine 160, and phenylalanine 90, and induction at late-log phase (OD(600) = 4.5). Under these conditions, dry cell weight of 6 +/- 0.2 g/l and gamma-interferon concentration of 2.15 +/- 0.1 g/l were obtained. Later, without changing the concentration ratio of amino acids and glucose, the effect of increase in the primary glucose concentration on productivity of gamma-interferon was investigated. It was found that 25 g/l glucose will result in maximum attainable biomass and recombinant human gamma-interferon. At improved conditions, a dry cell weight of 14 +/- 0.2 g/l, concentration and overall productivity of gamma-interferon 4.2 +/- 0.1 g/l and 420 +/- 10 mg/l h, respectively, were obtained.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655276     DOI: 10.1007/s12010-009-8718-5

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  8 in total

1.  Cloning, soluble expression, and purification of the RNA polymerase II subunit RPB5 from Saccharomyces cerevisiae.

Authors:  Gaurav Chhetri; Arabinda Ghosh; Ramesh Chinta; Sohail Akhtar; Timir Tripathi
Journal:  Bioengineered       Date:  2015-01-21       Impact factor: 3.269

Review 2.  Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.

Authors:  Hendrik Waegeman; Wim Soetaert
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-08       Impact factor: 3.346

3.  Optimization of medium composition to increase the expression of recombinant human interferon-β using the Plackett-Burman and central composite design in E. coli SE1.

Authors:  Dharam Pal; Gopal Patel; Prakashkumar Dobariya; Shivraj Hariram Nile; Abhay H Pande; Uttam Chand Banerjee
Journal:  3 Biotech       Date:  2021-04-19       Impact factor: 2.406

4.  Cloning, expression & evaluation of potential immunogenic recombinant capsid premembrane protein of West Nile virus.

Authors:  Jyoti S Kumar; Sivakumar Rathinam; Divanyshi Karothia; Manmohan Parida
Journal:  Indian J Med Res       Date:  2019-05       Impact factor: 2.375

5.  A Biotechnological Approach for the Production of Pharmaceutically Active Human Interferon-α from Raphanus sativus L. Plants.

Authors:  Rashad Kebeish; Emad Hamdy; Omar Al-Zoubi; Talaat Habeeb; Raha Osailan; Yassin El-Ayouty
Journal:  Bioengineering (Basel)       Date:  2022-08-10

6.  Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors.

Authors:  Javad Ranjbari; Valiollah Babaeipour; Hossein Vahidi; Hamidreza Moghimi; Mohammad Reza Mofid; Mohammad Mehdi Namvaran; Sevda Jafari
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

7.  Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus.

Authors:  Amrita Saha; Badri Narayan Acharya; Raj Priya; Nagesh K Tripathi; Ambuj Shrivastava; M Kameswara Rao; Pooja Kesari; Manju Narwal; Shailly Tomar; Sameer S Bhagyawant; Manmohan Parida; Paban Kumar Dash
Journal:  Sci Rep       Date:  2018-07-17       Impact factor: 4.379

8.  Development of Multispecies Recombinant Nucleoprotein-Based Indirect ELISA for High-Throughput Screening of Crimean-Congo Hemorrhagic Fever Virus-Specific Antibodies.

Authors:  Neha Shrivastava; Ambuj Shrivastava; Sandeep M Ninawe; Shashi Sharma; Jyoti S Kumar; Syed Imteyaz Alam; Amit Kanani; Sushil Kumar Sharma; Paban Kumar Dash
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.